SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-089195
Filing Date
2012-02-29
Accepted
2012-02-29 16:19:57
Documents
7
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d297459d10k.htm 10-K 1608131
2 LIST OF SUBSIDIARIES d297459dex211.htm EX-21.1 2380
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d297459dex231.htm EX-23.1 3406
4 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) d297459dex311.htm EX-31.1 7428
5 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) d297459dex312.htm EX-31.2 7517
6 CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) AND SECTION 1350 d297459dex321.htm EX-32.1 4643
7 GRAPHIC g297459g93z79.jpg GRAPHIC 42928
  Complete submission text file 0001193125-12-089195.txt   1693879
Mailing Address 3280 BAYSHORE BLVD BRISBANE CA 94005
Business Address 3280 BAYSHORE BLVD BRISBANE CA 94005 415 466 2200
INTERMUNE INC (Filer) CIK: 0001087432 (see all company filings)

IRS No.: 943296648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29801 | Film No.: 12653051
SIC: 2834 Pharmaceutical Preparations